Crystal Bioscience Inc.

Industry

  • Biotechnology
    • Transgenics
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
  • Pharmaceuticals

Other Names/Subsidiaries

  • Ligand Pharmaceuticals
See more in Biomedtracker

Latest on Crystal Bioscience Inc.

Scrip

Deal Watch: AbbVie Bets On Turnstone’s Cancer Immunotherapy Technology

 
• By Joseph Haas, Lubna Ahmed, John Davis, and Anju Ghangurde

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

In Vivo

Deals Shaping The Medical Industry, June 2016

IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere

In Vivo

Deals Shaping The Medical Industry, March 2014

IN VITRO DIAGNOSTICS Mergers & Acquisitions Becton Dickinson & Co. Alverix Inc. Becton Dickinson & Co. acquired its privately held point-of-care testing partner Alverix Inc. (optoelectronics)